| http://www.w3.org/ns/prov#value | - It is the first non-invasive, real-time, single beat, mapping solution to potentially improve the diagnosis and treatment of electrical abnormalities of the heart, including cardiac arrhythmias and congestive heart failure.Receiving the CE Mark is a significant milestone, and validates the ECVUE technology's evolution to a commercial-ready product, said Chief Executive Officer Steve Arless.
|
